Company Snapshot


Change Company Name
 
Goldline Pharmaceutical Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
544759
NSE Symbol
N.A
P/E
0
ISIN Demat
INE1CLW01015
Div & Yield %
0
EPS
0
Book Value
12.39
Market Cap (Rs Cr.)
0.00
Face Value
10
Stock Price Details
Last Price (₹) 59.75
Change 13.77 (32.02%)
Best Buy (₹) 0
Best Sell (₹) 56.77
Today's Range 56.77 - 60.00
52-Week Range 56.77 - 60.00
Beta (1 Year) NA
Chart
1 Day | 5 Day | 3 Month | 1 Year | 5 Year
Index Details
 
Corporate Announcements
Corporate Details
Incorporation Year : 2004
Chairman : AMOL LAXMIKANT MUJUMDAR
Ownership Group : Indian Private
Sector : Pharmaceuticals
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln
Registered Office :

Goldline Pharmaceutical Ltd
103 F-1 Leela Apartment Shilpa,
HSG Society Shanidham Narendra,
Nagpur,
Maharashtra - 440015,
Phone : +91 712 278 6666,
Fax : N.A.
E-Mail : info@goldlinepharma.in
URL : http://www.goldlinepharma.in
Investor Returns
Period Date Price(₹) Returns (%)
1Week
1Month
3Month
6Month
1Year
No Data Found
Mutual Funds Holding
Scheme Name % Holding Market Value (₹.Cr)
No Data Found
Peer Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln
Company Last Price(₹) Change(%) 52Week High(₹) 52Week Low(₹) Market Cap(₹)
Sun Pharmaceutical Industries Ltd 1,906.00 0.04 1,911.95 1,547.25 457,121.30
Cipla Ltd 1,422.90 -0.26 1,672.20 1,165.55 115,240.83
Dr Reddys Laboratories Ltd 1,332.50 0.08 1,377.95 1,149.00 111,126.23
Mankind Pharma Ltd 2,543.90 1.90 2,726.75 1,909.90 103,056.40
Lupin Ltd 2,268.00 0.67 2,492.00 1,838.65 103,010.73

Mail Us

Exclusive E-mail Id for redressal of investor grievances

jyotiinvestorgrievance@rediffmail.com
ATTENTION INVESTORS:
"Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.      |      " KYC is one time excercise while dealing in securities markets-once KYC is done through a SEBI registered intermediary (broker,DP,Mutual Fund etc),you need not undergo the same process again when you approach another intermediary."      |      "Contents which are exclusively for Non-Broking Products/Services, Mutual Fund, Mutual Fund-SIP, Research reports, Insurance, etc. where the Member is just a distributor. These are not Exchange traded product and the Member is just acting as distributor. It should also state that all disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism."      |      “The Stock Exchange, Mumbai is not in any manner answerable, responsible or liable to any person or persons for any acts of omission or commission, errors, mistakes and/or violation, actual or perceived, by us or our partners, agents, associates etc., of any of the Rules, Regulations, Bye-laws of the Stock Exchange, Mumbai, SEBI Act or any other laws in force from time to time. The Stock Exchange, Mumbai is not answerable, responsible or liable for any information on this Website or for any services rendered by our employees, our servants, and us. ”      |      "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account." .......... Issued in the interest of investors"
logo
Address

B- 78, 3rd Floor, Defence Colony
New Delhi – 110 024

RISK DISCLOSURES ON DERIVATIVES

Attention Investors

  • Stock Brokers can accept securities as margin only by pledge.
  • Update your mobile number & email Id with your Stock Broker/Depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.
  • Pay 20% upfront margin of the transaction value to trade in cash market segment.
  • Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.
  • Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month

Precautions for clients dealing in Options

  • Do not Share your trading credentials – login id & passwords including OTP’s.
  • Do not Trade in leveraged products like options without proper understanding, which could lead to losses.
  • Do not Write/ sell options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Do not Deals in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, calls, etc.
  • Do not Trade in “Options” based on recommendations from unauthorised / unregistered investment advisors and influencers.

NSE SEBI CM INZ000017939 | NSE SEBI F&O INZ000017939 | BSE SEBI CM INZ000017939 | NSDL : IN-DP-443-2019 | CDSL: IN-DP-443-2019 | NCDEX SEBI INZ000017939 | MCX SEBI INZ000017939

@2023 Jyoti Broking Pvt. Ltd. All rights reserved

Designed, developed and powered by CMOTS Infotech (ISO 9001:2015 certified)